Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > 50$ in 6 months

<< Previous

Bullboard Posts

Next >>

Comment by Apocalypseon Feb 08, 2022 10:04pm

86 Views

Post# 34410995

RE:RE:RE:50$ in 6 months

Wow, you really are quite dumb. All biotech's are down 90%.....really. What world do you live in. The one's that are down 90% are all the ones you go so hard on in making bat shite crazy predictions for. . What happened to your prediction about this being $250 Million last year. Hahahaha.

<< Previous

Bullboard Posts

Next >>

Consumer advocacy law firm investigates Microsoft over X-Box data concerns